PRELUDE CAPITAL MANAGEMENT, LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 321 filers reported holding GW PHARMACEUTICALS PLC in Q1 2019. The put-call ratio across all filers is 1.52 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$4,263,000
+339.5%
19,653
+111.8%
0.11%
+197.3%
Q4 2019$970,000
+6366.7%
9,277
+7036.2%
0.04%
+3600.0%
Q3 2019$15,000
-40.0%
130
-9.7%
0.00%0.0%
Q2 2019$25,000
-91.2%
144
-91.4%
0.00%
-93.8%
Q1 2019$283,000
-9.9%
1,679
-47.9%
0.02%
-23.8%
Q4 2018$314,000
-28.5%
3,220
+26.8%
0.02%
-16.0%
Q3 2018$439,000
-25.3%
2,540
-39.7%
0.02%
-32.4%
Q2 2018$588,000
+1.6%
4,213
-18.1%
0.04%
-11.9%
Q1 2018$579,000
+46.6%
5,143
+71.9%
0.04%
+31.2%
Q4 2017$395,000
+19.7%
2,992
+20.5%
0.03%
-8.6%
Q3 2016$330,000
+72.8%
2,483
-77.4%
0.04%
+12.9%
Q3 2013$191,00011,0000.03%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q1 2019
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 86,069$18,668,0008.69%
BARDIN HILL MANAGEMENT PARTNERS LP 170,108$36,897,0006.84%
HARVEST MANAGEMENT LLC 44,100$9,565,0005.72%
Twin Securities, Inc. 39,541$8,576,0005.50%
TIG Advisors, LLC 572,743$124,228,0004.67%
ALPINE ASSOCIATES MANAGEMENT INC. 787,500$170,810,0004.63%
First Trust Capital Management L.P. 105,822$22,953,0004.49%
Pentwater Capital Management LP 2,102,104$455,946,0004.35%
OMNI PARTNERS LLP 403,061$87,424,0004.31%
SPRING CREEK CAPITAL LLC 370,000$80,253,0003.47%
View complete list of GW PHARMACEUTICALS PLC shareholders